Phase 2 study of livmoniplimab in combination with budigalimab in patients with hepatocellular carcinoma Meeting Abstract
| Authors: | Abou-Alfa, G. K.; Chiu, C. F.; Piscaglia, F.; Sangro, B.; Henkel, A.; Fang, H.; Patel, M.; Ping, Z.; Sutherland, C.; Bako, E.; Ferlini, C. |
| Abstract Title: | Phase 2 study of livmoniplimab in combination with budigalimab in patients with hepatocellular carcinoma |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557406184 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.TPS4189 |
| Notes: | Meeting Abstract: TPS4189 -- Source: Wos |
